Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+11 more

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Stage IV Melanoma2 Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities1 Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)1 Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)1 Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)1 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)1 Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative1 Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable1

Affiliations

Dana-Farber Cancer Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

12 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiableAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+6 more

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score17%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Stage IV MelanomaStage IV Non-small Cell Lung Cancer

Similarity Score4%

Project Leader

Ono Pharmaceutical Co., Ltd.

47 trials

Shared therapeutic areas:

Recurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer

Similarity Score4%

Ido Wolf, MD

Tel-Aviv Sourasky Medical Center

1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score2%

Antony Magliocco, MD

Protean BioDiagnostics

1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score2%

Eugenie Younger, MD

Gloucestershire Hospitals NHS Foundation Trust

1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score2%

Andreas Polychronis, MD

Mount Vernon Cancer Centre

1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score2%

Adam Berger, MD

Rutgers Cancer Institute

1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score2%

Astrid Ammendola, MD

Asklepios Klinik Gauting GmbH

1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score2%

Igor Puzanov, MD

Roswell Park

1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer

Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01026324Phase 1/2PrincipalInvestigator

Dinaciclib in Treating Patients With Stage III-IV Melanoma

Stage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma

Terminated

NCT00039091Phase 1PrincipalInvestigator

Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+11 more

Terminated

All 2 trials loaded